COMMUNIQUÉS West-GlobeNewswire

RAPT Therapeutics Announces Proposed Public Offering of Common Stock
21/10/2025
SOUTH SAN FRANCISCO, Calif., Oct. 21, 2025 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT) (“RAPT”), a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and [...]
NurExone Invited Presenter at Precision EV Forum in Cambridge, UK
21/10/2025
Highlighting Regulatory and Clinical Leadership in Regenerative Exosome Therapies TORONTO and HAIFA, Israel, Oct. 21, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or [...]
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
21/10/2025
CONSHOHOCKEN, Pa., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated [...]
InspireMD to Announce Third Quarter 2025 Financial Results
21/10/2025
MIAMI, Oct. 21, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard® Prime carotid stent system for the prevention of stroke, today announced that it will release its third quarter 2025 [...]
Eagle Pharmaceuticals Announces Results of 2025 Annual Meeting of Stockholders
21/10/2025
WOODCLIFF LAKE, N.J., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. (OTCMKTS: EGRX) (the “Company” or “Eagle”) is pleased to announce the voting results for each of the matters presented at the Company’s [...]
Inotiv, Inc. to Participate in Three Investor Conferences in November 2025
21/10/2025
WEST LAFAYETTE, Ind., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and [...]
Terns Pharmaceuticals Reports Topline 12-week Data from its Phase 2 Trial Evaluating Oral GLP-1 Receptor Agonist TERN-601 in Obesity
21/10/2025
Results show maximum placebo-adjusted weight loss of 4.6% with 12% treatment discontinuation due to adverse events Asymptomatic, reversible grade 3 liver enzyme elevations occurred in three participants during post- [...]
Intuitive Announces Third Quarter Earnings
21/10/2025
SUNNYVALE, Calif., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Intuitive (the “Company”) (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced financial [...]
Exagen Inc. to Announce Third Quarter 2025 Financial Results on November 4, 2025
21/10/2025
CARLSBAD, Calif., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of innovative autoimmune testing, will release financial results for the quarter ended September 30, 2025, before the [...]
Ceribell to Report Third Quarter 2025 Financial Results on November 4, 2025
21/10/2025
SUNNYVALE, Calif., Oct. 21, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological [...]
Aveanna Healthcare Holdings Announces Preliminary Third Quarter Financial Results
21/10/2025
ATLANTA, Oct. 21, 2025 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient populations, today [...]
Teva et Prestige Biopharma concluent un accord de licence pour la commercialisation de Tuznue® en Europe
21/10/2025
Teva et Prestige annoncent un accord de licence et d’approvisionnement pour la commercialisation de Tuznue ® , un biosimilaire d’Herceptin ® (trastuzumab) produit par Prestige Tuznue ® a reçu l’autorisation de mise sur [...]
Aveanna Announces Launch of Secondary Offering of Common Stock
21/10/2025
ATLANTA, Oct. 21, 2025 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient populations, [...]
STERIS to Host a Conference Call for Fiscal 2026 Second Quarter Results on November 6, 2025
21/10/2025
DUBLIN, IRELAND, Oct. 21, 2025 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2026 second quarter results at 9:00 a.m. ET [...]
Jushi Holdings Inc. to Report Third Quarter 2025 Financial Results on November 4, 2025
21/10/2025
BOCA RATON, Fla., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH) (OTCQX: JUSHF) , a vertically integrated, multi-state cannabis operator, announced that it expects to report [...]
Supernus Pharmaceuticals to Announce Third Quarter 2025 Financial Results and Host Conference Call on November 4, 2025
21/10/2025
ROCKVILLE, Md., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system [...]
Sotera Health Announces Third-Quarter 2025 Earnings Release Date
21/10/2025
CLEVELAND, Oct. 21, 2025 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare [...]
Raw Garden Acquires “California Love” to Grow Their Clean Cannabis Movement
21/10/2025
Acquisition strengthens Raw Garden’s mission to expand access to clean cannabis across California SANTA BARBARA, Calif., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Raw Garden, California’s leader in clean cannabis for over a [...]
Curia Sterile Drug Product Facility Named Massachusetts Manufacturer of the Year
21/10/2025
ALBANY, N.Y., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Curia Global, Inc. (Curia), a leading contract research, development and manufacturing organization, today announced its Burlington, MA sterile drug product facility has [...]

Pages